EEOC Updates Guidance Related to COVID-19 Testing - Bim Group

EEOC Updates Guidance Related to COVID-19 Testing

( 2 MINUTE READ )

The Equal Employment Opportunity Commission (“EEOC”) recently updated its COVID-19 Guidance Page.  The revised guidance advised that general testing administered by employers consistent with current CDC guidance will meet the ADA’s “business necessity” standard. However, in order for an employer to test only one employee, the employer should have a reasonable objective belief that he/she might have the disease.

The EEOC guidance states that an employer can ask employees whether they have had contact with anyone diagnosed with COVID-19 or who may have symptoms associated with the disease, but should not phrase that question as one asking about family members.  The ADA allows an employer to bar an employee from physical presence in the workplace if he or she refuses to have a temperature taken or refuses to answer questions about whether he or she has COVID-19, has symptoms associated with COVID-19, or has been tested for COVID-19.

Test and screening results must remain confidential, but an employer can notify others in the workplace that someone has COVID as long as they don’t identify the affected employee.

The EEOC also states that allowing telework now does not mean an employer must allow it when the pandemic ends. The EEOC guidance reads, “The fact that an employer temporarily excused performance of one or more essential functions when it closed the workplace and enabled employees to telework for the purpose of protecting their safety from COVID-19, or otherwise chose to permit telework, does not mean that the employer permanently changed a job’s essential functions, that telework is always a feasible accommodation, or that it does not pose an undue hardship. These are fact-specific determinations.” However, the guidance also states, “The period of providing telework because of the COVID-19 pandemic could serve as a trial period that showed whether or not [an] employee with a disability could satisfactorily perform all essential functions while working remotely.”

 

Consult with your own attorney before taking any action. In my role at Bim Group, I cannot provide legal advice. This information is provided for educational purposes only; it’s not intended to provide legal advice. Thank you.

Recent Insights

November 29, 2023
News

Important Reminder: Gag Clause Attestation Due 12/31/23

The Consolidated Appropriations Act of 2021 (the CAA) requires group health plans to attest compliance with the CAA’s gag clause prohibition on an annual basis. While the prohibition of gag clauses was effective December 27, 2020, the first annual attestation is due December 31, 2023. Group health plan sponsors should begin taking steps now to […]
Read more
November 20, 2023
News

New PCORI Fee Announced by IRS

READ TIME:  7 MINUTES The Internal Revenue Service (IRS) recently released the adjusted Patient-Centered Outcomes Research Institute (PCORI) fee rate for policy and plan years ending on or after October 1, 2023, and before October 1, 2024. Background The Affordable Care Act (ACA) imposed a fee on issuers of fully insured plans and plan sponsors […]
Read more
November 20, 2023
HHS

HHS Announces Civil Penalties for HIPAA, ACA, and MSP Violations

READ TIME: 5 MINUTES On October 6, 2023, the Department of Health and Human Services (HHS) released inflation-related penalty adjustments for violations of the Health Insurance Portability and Accountability Act (HIPAA), Affordable Care Act (ACA), and the Medicare Secondary Payer (MSP) rules. These adjusted amounts apply to penalties assessed on or after October 6, 2023, […]
Read more
November 20, 2023
Webinar

Webinar: Year-End Compliance and What to Expect in 2024

Tuesday, December 12, 2023 1 – 2PM CST Register Now Registration Code:UBA410EW   Attend this month’s webinar to review 2023 employee benefits compliance requirements and learn about compliance challenges employers will face in 2024. Gain insights into: Reproductive healthcare and contraceptive coverage requirements Prescription drug and healthcare reporting Consolidated Appropriations Act components that may impact […]
Read more